Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O'Day SJ, Sosman JA, Kirkwood JM, Eggemont AMM, Dreno B, Nolop K, Nelson B, Jou J, Lee RJ, Flaherti KT, McArthur GA.
Improved survival with vemarafenib in melanoma with BRAF V600E mutation.
N Engl J Med 2011;364:2507-16. [Ref.ID 91354]